Ringman John M, Liang Li-Jung, Zhou Yan, Vangala Sitaram, Teng Edmond, Kremen Sarah, Wharton David, Goate Alison, Marcus Daniel S, Farlow Martin, Ghetti Bernardino, McDade Eric, Masters Colin L, Mayeux Richard P, Rossor Martin, Salloway Stephen, Schofield Peter R, Cummings Jeffrey L, Buckles Virginia, Bateman Randall, Morris John C
1 Mary S. Easton Centre for Alzheimer's Disease Research at UCLA, 10911 Weyburn Ave., #200, Los Angeles, CA, 90095, USA
2 David Geffen School of Medicine at UCLA, Dept. of Medicine, 911 Broxton, Los Angeles, CA, 90024, USA.
Brain. 2015 Apr;138(Pt 4):1036-45. doi: 10.1093/brain/awv004. Epub 2015 Feb 15.
Prior studies indicate psychiatric symptoms such as depression, apathy and anxiety are risk factors for or prodromal symptoms of incipient Alzheimer's disease. The study of persons at 50% risk for inheriting autosomal dominant Alzheimer's disease mutations allows characterization of these symptoms before progressive decline in a population destined to develop illness. We sought to characterize early behavioural features in carriers of autosomal dominant Alzheimer's disease mutations. Two hundred and sixty-one persons unaware of their mutation status enrolled in the Dominantly Inherited Alzheimer Network, a study of persons with or at-risk for autosomal dominant Alzheimer's disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Geriatric Depression Scale and the Clinical Dementia Rating Scale (CDR). Ninety-seven asymptomatic (CDR = 0), 25 mildly symptomatic (CDR = 0.5), and 33 overtly affected (CDR > 0.5) autosomal dominant Alzheimer's disease mutation carriers were compared to 106 non-carriers with regard to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of depressive symptoms on the Geriatric Depression Scale using generalized linear regression models with appropriate distributions and link functions. Results from the adjusted analyses indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less common in cognitively asymptomatic mutation carriers than in non-carriers (5% versus 17%, P = 0.014) and the odds of experiencing at least one behavioural sign in cognitively asymptomatic mutation carriers was lower than in non-carriers (odds ratio = 0.50, 95% confidence interval: 0.26-0.98, P = 0.042). Depression (56% versus 17%, P = 0.0003), apathy (40% versus 4%, P < 0.0001), disinhibition (16% versus 2%, P = 0.009), irritability (48% versus 9%, P = 0.0001), sleep changes (28% versus 7%, P = 0.003), and agitation (24% versus 6%, P = 0.008) were more common and the degree of self-rated depression more severe (mean Geriatric Depression Scale score of 2.8 versus 1.4, P = 0.006) in mildly symptomatic mutation carriers relative to non-carriers. Anxiety, appetite changes, delusions, and repetitive motor activity were additionally more common in overtly impaired mutation carriers. Similar to studies of late-onset Alzheimer's disease, we demonstrated increased rates of depression, apathy, and other behavioural symptoms in the mildly symptomatic, prodromal phase of autosomal dominant Alzheimer's disease that increased with disease severity. We did not identify any increased psychopathology in mutation carriers over non-carriers during the presymptomatic stage, suggesting these symptoms result when a threshold of neurodegeneration is reached rather than as life-long qualities. Unexpectedly, we found lower rates of depressive symptoms in cognitively asymptomatic mutation carriers.
先前的研究表明,抑郁、冷漠和焦虑等精神症状是早期阿尔茨海默病的危险因素或前驱症状。对有50%遗传常染色体显性阿尔茨海默病突变风险的人群进行研究,能够在注定会患病的人群出现病情进展性衰退之前,对这些症状进行特征描述。我们试图对常染色体显性阿尔茨海默病突变携带者的早期行为特征进行描述。261名不知道自己突变状态的人参加了显性遗传阿尔茨海默病网络研究,该研究针对常染色体显性阿尔茨海默病患者或有患病风险的人群,使用神经精神科问卷、15项老年抑郁量表和临床痴呆评定量表(CDR)进行评估。将97名无症状(CDR = 0)、25名轻度症状(CDR = 0.5)和33名明显受影响(CDR > 0.5)的常染色体显性阿尔茨海默病突变携带者与106名非携带者在神经精神科问卷上的行为症状频率以及老年抑郁量表上的抑郁症状严重程度方面进行比较,采用具有适当分布和连接函数的广义线性回归模型。调整分析结果表明,神经精神科问卷上的抑郁症状在认知无症状突变携带者中比在非携带者中更少见(5%对17%,P = 0.014),认知无症状突变携带者出现至少一种行为体征的几率低于非携带者(优势比 = 0.50,95%置信区间:0.26 - 0.9S,P = 0.042)。与非携带者相比,轻度症状突变携带者中抑郁(56%对17%,P = 0.0003)、冷漠(40%对4%,P < 0.0001)、脱抑制(16%对2%,P = 0.009)、易怒(48%对9%,P = 0.0001)、睡眠改变(28%对7%,P = 0.003)和激越(24%对6%,P = 0.008)更为常见,且自评抑郁程度更严重(老年抑郁量表平均得分2.8对1.4,P = 0.006)。焦虑、食欲改变、妄想和重复运动活动在明显受损的突变携带者中也额外更为常见。与晚发型阿尔茨海默病的研究相似,我们证明在常染色体显性阿尔茨海默病的轻度症状前驱期,抑郁、冷漠和其他行为症状的发生率增加,且随疾病严重程度加重。我们未发现无症状阶段突变携带者的精神病理学表现比非携带者增加,这表明这些症状是在达到神经退行性变阈值时出现,而非作为终生特质。出乎意料的是,我们发现认知无症状突变携带者的抑郁症状发生率较低。